Kelly E. Dooley - Publications

Tuberculosis Prevention in Pregnant Women Living with HIV: A Review of the Current Management Strategies and Guidance.

Journal: Infection and drug resistance

Published: March 04, 2026

Effect of HIV on bedaquiline and delamanid pharmacokinetics in patients with multidrug-resistant TB.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: February 10, 2026

Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020.

Journal: Emerging infectious diseases

Published: January 06, 2026

Pharmacokinetics of Twice-daily Tenofovir Alafenamide in Adults With HIV-associated Tuberculosis on Bictegravir/Emtricitabine/Tenofovir Alafenamide and Rifampicin.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 05, 2025

REVOLUTIONIZING TUBERCULOSIS REGIMEN DEVELOPMENT.

Journal: Transactions of the American Clinical and Climatological Association

Published: August 07, 2025

Intensified Treatment of Tuberculous Meningitis in Adults: A Systematic Review and Meta-analysis.

Journal: Open forum infectious diseases

Published: June 13, 2025

Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design.

Journal: Contemporary clinical trials

Published: June 05, 2025

Efficacy of isoniazid in paediatric tuberculosis: an individual participant data meta-analysis.

Journal: The European respiratory journal

Published: May 19, 2025

Evidence Generation for a Host-Response Biosignature of Respiratory Disease.

Journal: Viruses

Published: May 16, 2025

Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.

Journal: Nature communications

Published: May 13, 2025

Mycobacterium avium complex (MAC) elimination slopes from sputum are potential treatment response biomarkers in patients with HIV and pulmonary MAC.

Journal: IJTLD open

Published: May 08, 2025

Fixed-dose combination bictegravir-emtricitabine-tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial.

Journal: The lancet. HIV

Published: April 16, 2025